摘要
目的:研究三七、绞股蓝单方及配伍方对实验性兔动脉粥样硬化(AS)模型血管重构的影响。方法:64只3—4月龄新西兰雄兔随机分为正常组(Contr01)、模型组(Model)、三七组(sQ)、绞股蓝组(JGL)、复方组(FF)、卡托普利组(Captopril)。除正常对照组外,均予耳缘静脉注射牛血清白蛋白250mg/ks后继喂高脂饲料,同时各药物组给予相应的药物,连续12周。于12周末行胸主动脉HE、EF(弹力纤维)染色,观测VSMC(血管平滑肌细胞)核个数、EF的变化;免疫组织化学标记胸主动脉PCNA(增殖细胞核心抗原)、TGF—β1(转化生长因子-β1)表达。结果:(1)与模型组比较,各药物组主动脉病变不同程度减轻,尤以复方组为优;(2)复方组与模型组比较VSMC核个数显著下降;(3)模型组与正常组比较,主动脉PCNA数密度百分数、TGF—β1面积百分比显著升高(P〈0.01),各药物组有不同程度的降低。结论:三七、绞股蓝及复方通过降低TGF—B1表达,减轻该因子致细胞增殖的作用,减轻血管壁肥厚性重构。
Objective: To investigate the effects and mechanisms of Panax notoginseng (SQ) and Gynostemma pentaphyllum(JGL) on vascular remodeling. Methods: A total of sixity-four male New Zealand rabbits was randomly divided into six groups:Normal, Model, SQ, JGL, FF(SQ + JGL) and Captopril. The rabbits in control group were fed with regular diet, others were injected with bovine serum albumin 250 mg/kg and fed with high cholesterol diet, meanwhile, durgs were administrated orally. Rabbits were sacrificed at the end of 12 week,aortas serial cross-sections were stained with hematoxylin-eosin and elastic fibers. Immunohistochemistry were performed to label PCNA and TGF-β1. Results:(1) The pathological changes of all drug treated groups were alleviated. (2)Compound prescription decreased the quantity of aorta VSMC nucleus compared with model group( P 〈 0.05). (3)The aorta PCNA immunostaining number and TGF-β1 immunostaining area of model group were significantly higher than normal group ( P 〈 0.01 ), all drug treated groups decreased. Conclusion:Reduced expression of TGF-β1 ,and cellular proliferation may be related with inhibition of VR.
出处
《中国实验方剂学杂志》
CAS
2007年第8期24-28,共5页
Chinese Journal of Experimental Traditional Medical Formulae
关键词
动脉粥样硬化
血管重构
三七
绞股蓝
atherosclerosis
vascular remodeling
Panax notoginseng
Gynostemma pentaphyUum